Analysts have been eager to weigh in on the Healthcare sector with new ratings on Demant (WILLF – Research Report) and Grifols SA (GRFS – Research Report).
Demant (WILLF)
In a report issued on February 6, Maja Pataki from Kepler Capital maintained a Hold rating on Demant, with a price target of DKK270.00. The company’s shares closed last Wednesday at $43.88, close to its 52-week high of $44.83.
According to TipRanks.com, Pataki is ranked #8570 out of 8702 analysts.
The word on The Street in general, suggests a Moderate Sell analyst consensus rating for Demant with a $44.03 average price target, a 0.3% upside from current levels. In a report released yesterday, Danske Bank also downgraded the stock to Hold with a DKK360.00 price target.
See Insiders’ Hot Stocks on TipRanks >>
Grifols SA (GRFS)
Kepler Capital analyst Pablo de Renteria maintained a Buy rating on Grifols SA on February 6 and set a price target of EUR17.00. The company’s shares closed last Wednesday at $8.15.
According to TipRanks.com, Renteria is ranked #8321 out of 8702 analysts.
Currently, the analyst consensus on Grifols SA is a Moderate Buy with an average price target of $15.85.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on WILLF:
